Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
Investigators examined the time to first event composing of cardiovascular death, myocardial infarction, or stroke.
All articles by Anna Kitabjian
Cardiovascular Mortality in Individuals With Early-, Late-Onset Prediabetes
Investigators examined the frequency of cardiovascular vs noncardiovascular deaths in individuals who developed prediabetes that did not progress to diabetes.
Predictive Value of Idiopathic PAH Risk Assessment Using Comorbidities, Age
Ischemic heart disease and kidney dysfunction were identified as 2 comorbidities that may affect outcomes in idiopathic pulmonary arterial hypertension.
Smoking Cessation Pharmacotherapies May Not Increase MACE
There were no observable differences in the incidence of any cardiovascular events across the smoking cessation treatment groups.
Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
Further studies are needed to assess whether beta-blockers are effective in reducing mortality and coronary events in patients with diabetes receiving optimal medical treatment.
Noninvasive CAD Screening May Reduce Cardiac Events in Individuals With Asymptomatic Diabetes
Compared with standard care, noninvasive coronary artery disease screening reduced cardiac events by 27% in individuals with asymptomatic diabetes. Results justify larger, appropriately powered trials to potentially revisit current recommendations.
Pulmonary Arterial Hypertension Identified Via Claims-Based Algorithm
Patients with pulmonary arterial hypertension may be better identified with the use of a claims-based algorithm that includes ICD-9-CM codes, electronic medical records, and more.
Pulmonary Embolism Rule-Out Criteria Can Identify Thromboembolic Events
A 3-month risk for a thromboembolic event was assessed using a pulmonary embolism rule-out criteria strategy and compared with a conventional strategy in patients with a low clinical probability of pulmonary embolism.
Pulmonary Embolism Risk Prediction in Postpartum Women
Certain risk scores may not be reliable for predicting the presence of a pulmonary embolism in pregnant or postpartum women.
Pulmonary Hypertension Treatments Targeting NO Pathway Compared for Safety
Several drugs may demonstrate different safety profiles and side effects that warrant a change in treatment for individuals with pulmonary hypertension.
-
Loading...
-
Loading...
Next post in Pulmonary Vasculature
